Most Recent
ASIC’s ‘excessive’ 6-year ban on financial advisor cut in half
An Administrative Review Tribunal has halved a six-year ban on a former United Global Capital financial advisor imposed by the Australian Securities and Investments Commission, calling the ban "excessive".
Court tosses exam orders against Moreton Resources execs, Colin Biggers lawyers
A court has largely set aside examination orders against executives and solicitors for oil and gas company Moreton Resources and MRV Metals, finding they were an abuse of process. 
Construction PRO
Subcontractor’s failure to give builder SOPA submissions ‘fatal’: appeals court
A head contractor has successfully challenged a Queensland Supreme Court decision, which tossed its case against a SOPA adjudication decision for a subcontractor on a building project in Southport.
The King’s School headmaster settles Fair Work case
The headmaster of The King’s School has settled Fair Work proceedings brought against the elite Sydney school late last year. 
Construction PRO
Judge rejects ‘trial by ambush’ in dispute between Queensland property developers
A judge has rejected amendments based on "buried" documents by developer Golden Eagle Property Group, in a protracted case by the receiver of parent company GGPG. 
Target defeats split trial bid in fight over convertible stroller recall
A judge has refused to bifurcate a dispute between Smart Trikes and Target over the supply and eventual recall of allegedly unsafe convertible strollers, finding any time and cost savings were likely to prove illusory. 
Construction PRO
QCAT can review rectification decision outside time, appeal member says
A QCAT ruling not to review a rectification decision because more than six and a half years had passed since completion of construction has been set aside, with the tribunal finding on review that the time limit rule was misapplied.
Merck fails to block Pfizer’s RSV vaccine trade mark
Merck KGaA has failed to block Pfizer’s 'Abrysvo' trade mark for its RSV vaccine, with a delegate finding no likelihood of confusion with the mark for Merck’s Mavenclad MS drug despite their visual similarities. 
Construction PRO
Villawood director can’t bring alternative argument in dispute over $295M property
A director of developer Villawood has lost his bid to bring an alternative claim in his case against the company’s subsidiary alleging he is entitled to part of a property said to be worth $295 million.
Ex-Passivhaus CEO claims she was sacked for raising governance issues
A judge has declined to reinstate the ex-CEO of sustainable building not-for-profit Australia Passivhaus Association while her suit alleging she was unlawfully terminated after complaining about serious governance issues moves forward.